Home » Topics » Regulatory » EMA

EMA
RSS

Gentium receives day 180 list from EMA for defibrotide MAA

May 7, 2012

EMA committee maintains recommendation on Glybera

April 23, 2012

European approval of Forxiga recommended

April 23, 2012

CHMP recommends approval of Jakavi

April 23, 2012

CHMP issues positive opinion on SkyePharma asthma therapy

April 23, 2012

Takeda announces CHMP opinion on Rienso

April 23, 2012

Novartis announces changes in fingolimod labeling in U.S. and E.U.

April 23, 2012

CHMP confirms MAA opinion on Folotyn

April 23, 2012

Raptor Pharmaceutical submits NDA for RP-103

April 3, 2012

Ultragenyx obtains orphan drug designations in Europe for two lead products

March 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...